Cargando…

Diagnosis and Management of Fingolimod-Associated Macular Edema

OBJECTIVE: To investigate the clinical features, treatment, and prognosis of fingolimod-associated macular edema (FAME) and to provide a reference for its rational management. METHODS: FAME-related case reports were included in a pooled analysis by searching Chinese and English databases from 2010 t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Chunjiang, Deng, Zhenzhen, Song, Liying, Sun, Wei, Zhao, Shaoli
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9334868/ https://www.ncbi.nlm.nih.gov/pubmed/35911881 http://dx.doi.org/10.3389/fneur.2022.918086

Ejemplares similares

Acute onset of fingolimod-associated macular edema
por: Soliman, Mohamed Kamel, et al.
Publicado: (2016)

Fingolimod-associated severe bilateral cystoid macular edema
por: Fukuoka, Hideki, et al.
Publicado: (2022)

Fingolimod-Associated Macular Edema in the Treatment of Multiple Sclerosis
por: Khan, Asma A, et al.
Publicado: (2023)

Fingolimod Associated Bilateral Cystoid Macular Edema—Wait and See?
por: Pul, Refik, et al.
Publicado: (2016)

Continuing fingolimod after development of macular edema: A case report
por: Li, Vivien, et al.
Publicado: (2014)

Fingolimod-associated macular edema controlled with nepafenac non-steroidal anti-inflammatory opthalmologic applications
por: Husmann, Rachel, et al.
Publicado: (2020)

Visual function and disability are associated with microcystic macular edema, macular and peripapillary vessel density in patients with neuromyelitis optica spectrum disorder
por: Li, Jin, et al.
Publicado: (2022)

Valproic-induced Fanconi syndrome: Clinical features, risk factors, diagnosis and management
por: Wang, Chunjiang, et al.
Publicado: (2022)

Improvement of macular edema without discontinuation of fingolimod in a patient with multiple sclerosis: A case report
por: Akiyama, Hisanao, et al.
Publicado: (2016)

Incidence of uveitis and macular edema among patients taking fingolimod 0.5 mg for multiple sclerosis
por: Sonne, Scott Joseph, et al.
Publicado: (2020)

Functional Connectivity Changes After Initial Treatment With Fingolimod in Multiple Sclerosis
por: Petsas, Nikolaos, et al.
Publicado: (2019)

Non-traumatic Acute Epidural Hematoma in Multiple Sclerosis Treated With Fingolimod
por: Fukai, Ryoko, et al.
Publicado: (2019)

Fingolimod Leads to Immediate Immunological Changes Within 6 h After First Administration
por: Sehr, Tony, et al.
Publicado: (2020)

Medical management of cerebral edema in large hemispheric infarcts
por: DeHoff, Grace, et al.
Publicado: (2022)

Higher Cho/NAA Ratio in Postoperative Peritumoral Edema Zone Is Associated With Earlier Recurrence of Glioblastoma
por: Cui, Yong, et al.
Publicado: (2020)

Brain Atrophy Rates for Stable Multiple Sclerosis Patients on Long-Term Fingolimod versus Glatiramer Acetate
por: Honce, Justin M., et al.
Publicado: (2020)

Descriptive Analysis of Real-World Data on Fingolimod Long-Term Treatment of Young Adult RRMS Patients
por: Ziemssen, Tjalf, et al.
Publicado: (2021)

Increased Within-Network Functional Connectivity May Predict NEDA Status in Fingolimod-Treated MS Patients
por: Piervincenzi, Claudia, et al.
Publicado: (2021)

Case Report: Persisting Lymphopenia During Neuropsychiatric Tumefactive Multiple Sclerosis Rebound Upon Fingolimod Withdrawal
por: Koska, Valeria, et al.
Publicado: (2021)

Editorial: Mechanisms, Measurement, and Management of Vasogenic Edema After Stroke
por: Broocks, Gabriel, et al.
Publicado: (2022)

Clinical features, diagnosis and management of amoxicillin-induced Kounis syndrome
por: Wang, Chunjiang, et al.
Publicado: (2022)

Updates in the Management of Diabetic Macular Edema
por: Mathew, Christopher, et al.
Publicado: (2015)

Update on the Management of Uveitic Macular Edema
por: Teper, Slawomir Jan
Publicado: (2021)

Strategy for the Management of Diabetic Macular Edema: The European Vitreo-Retinal Society Macular Edema Study
por: Adelman, Ron, et al.
Publicado: (2015)

LETTER TO THE EDITOR Screening for Fingolimod Associated Macular Oedema: Experience Versus Guidelines
por: Moosavi, R, et al.
Publicado: (2014)

Rebound After Fingolimod and a Single Daclizumab Injection in a Patient Retrospectively Diagnosed With NMO Spectrum Disorder—MRI Apparent Diffusion Coefficient Maps in Differential Diagnosis of Demyelinating CNS Disorders
por: Wagner, Franca, et al.
Publicado: (2018)

A Comprehensive Monitoring Study on Electrocardiographic Assessments and Cardiac Events After Fingolimod First Dose—Possible Predictors of Cardiac Outcomes
por: Limmroth, Volker, et al.
Publicado: (2020)

When is macular edema not macular edema? An update on macular telangiectasia type 2
por: Wu, Lihteh
Publicado: (2015)

Corrigendum to “Strategy for the Management of Diabetic Macular Edema: The European Vitreo-Retinal Society Macular Edema Study”
por: Adelman, Ron A., et al.
Publicado: (2015)

Association of Brain Iron Overload With Brain Edema and Brain Atrophy After Intracerebral Hemorrhage
por: Liu, Ran, et al.
Publicado: (2020)

Fingolimod Inhibits Inflammation but Exacerbates Brain Edema in the Acute Phases of Cerebral Ischemia in Diabetic Mice
por: Li, Wanlu, et al.
Publicado: (2020)

Case Report: Findings Suggestive of Paraclinical Progressive Multifocal Leukoencephalopathy and Lung Cancer-Derived Brain Metastases in an MS Patient Treated With Fingolimod
por: Maass, Fabian, et al.
Publicado: (2021)

Analysis of Clinical Features of Kounis Syndrome Induced by Cephalosporin
por: Fang, Weijin, et al.
Publicado: (2022)

Radiomics features from perihematomal edema for prediction of prognosis in the patients with basal ganglia hemorrhage
por: Zhou, Peng, et al.
Publicado: (2022)

Anti-VEGF for the Management of Diabetic Macular Edema
por: Stefanini, Francisco Rosa, et al.
Publicado: (2014)

The role of aflibercept in the management of diabetic macular edema
por: Chang, Andrew A, et al.
Publicado: (2015)

Diabetic macular edema: Evidence-based management
por: Browning, David J, et al.
Publicado: (2018)

Is Edema Zone Volume Associated With Ki-67 Index in Glioblastoma Patients?
por: Caramanti, Ricardo, et al.
Publicado: (2022)

Natalizumab versus fingolimod for patients with active relapsing-remitting multiple sclerosis: results from REVEAL, a prospective, randomised head-to-head study
por: Butzkueven, Helmut, et al.
Publicado: (2020)

Early Bilateral Cystoid Macular Oedema Secondary to Fingolimod in Multiple Sclerosis
por: Liu, Lei, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_rovctvoardvo50d9b7iaoge7v3